Ha, H., Nam, A., Bang, J., Park, J., Kim, T., Lee, K., . . . Oh, D. (2016). Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy. Oncotarget, 7(47), 76604-76612. https://doi.org/10.18632/oncotarget.12810
Chicago-Zitierstil (17. Ausg.)Ha, Hyerim, et al. "Soluble Programmed Death-ligand 1 (sPDL1) and Neutrophil-to-lymphocyte Ratio (NLR) Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with Palliative Chemotherapy." Oncotarget 7, no. 47 (2016): 76604-76612. https://doi.org/10.18632/oncotarget.12810.
MLA-Zitierstil (9. Ausg.)Ha, Hyerim, et al. "Soluble Programmed Death-ligand 1 (sPDL1) and Neutrophil-to-lymphocyte Ratio (NLR) Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with Palliative Chemotherapy." Oncotarget, vol. 7, no. 47, 2016, pp. 76604-76612, https://doi.org/10.18632/oncotarget.12810.